Pv-aCO₂ Gap-Guided Resuscitation in Adult Polytrauma Patients: A Prospective Randomized Controlled Trial
Evaluation of Effect of Pv-aCO2-Gap on Clinical Outcomes With Standard Resuscitation End-points in Adult Poly-trauma Patients Admitted to the ICU --- Prospective Randomized Control Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
dult patients with multiple traumatic injuries admitted to the ICU from the operating room, emergency department, or hospital wards who meet the study criteria will be included after obtaining informed consent from the patient or their legal guardian. Participants will be randomly divided into two groups: one group will receive treatment guided by the difference between carbon dioxide levels in venous and arterial blood, while the other group will receive treatment based on standard resuscitation parameters commonly used in critical care. As part of routine monitoring, all patients will have a central venous catheter and an arterial line inserted to measure blood parameters. Blood samples from both lines will be taken shortly after ICU admission and at regular intervals during the first three days. These samples will be analyzed using a bedside blood gas machine, and the results will be compared between the two groups to determine whether monitoring the difference in carbon dioxide levels between venous and arterial blood improves patient outcomes compared with standard care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Mar 2026
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2026
CompletedStudy Start
First participant enrolled
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 16, 2026
CompletedMarch 18, 2026
March 1, 2026
3 months
March 15, 2026
March 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of mechanical ventilation
This will be the number of days of ventilatory support once patient is admitted to ICU
Secondary Outcomes (3)
ICU stay
This will the total length of ICU stay measured in number of days
ICU Mortality
This will be the death occurring during ICU stay
qSOFA score
This will be measured at time of admission in ICU then at 48h and 72h following admission
Study Arms (2)
Carbondioxide gap group
EXPERIMENTALConventional resuscitation group
ACTIVE COMPARATORInterventions
Arterial and central venous blood samples will be obtained for blood gas analysis using a point-of-care blood gas analyzer (ABL800 FLEX®, Radiometer). Sampling will be performed within 1 hour of ICU admission and subsequently at 6, 12, 24, 48, and 72 hours during the ICU stay. The measurements will be used to assess arterial and venous blood gas parameters for monitoring and guiding patient management.
Patients in this group will be managed using standard resuscitation parameters, including monitoring of arterial base deficit, arterial pH, serum lactate levels, and bicarbonate levels. These parameters will be measured through arterial blood gas analysis within 1 hour of admission to the ICU and subsequently at 6, 12, 24, 48, and 72 hours during the ICU stay, and will be used to guide ongoing resuscitation and clinical management.
Eligibility Criteria
You may qualify if:
- Either Gender
- Poly-trauma patients
- ○ Both penetrating and blunt trauma
- Both surgical and non-surgical
- Shock States
You may not qualify if:
- Any Chest trauma
- Patients with Obstructive and restrictive lung disease
- Obstructive sleep apnea
- Septic shock
- Pregnant patients
- Patients who will require readmission within 48 h after step-down from the ICU.
- Patients who will need extra-corporeal membrane oxygenation support
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesia, Pakistan Institute of Medical Sciences
Islamabad, Federal, 44000, Pakistan
Related Publications (1)
Doppmann P, Meuli L, Sollid SJM, Filipovic M, Knapp J, Exadaktylos A, Albrecht R, Pietsch U. End-tidal to arterial carbon dioxide gradient is associated with increased mortality in patients with traumatic brain injury: a retrospective observational study. Sci Rep. 2021 May 17;11(1):10391. doi: 10.1038/s41598-021-89913-x.
PMID: 34001982BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 15, 2026
First Posted
March 18, 2026
Study Start
March 16, 2026
Primary Completion
June 16, 2026
Study Completion
June 16, 2026
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Hospital Ethical committee doesnt allow data sharing